Antinuclear Antibodies: A Marker Associated with Steroid Dependence in Patients with Ulcerative Colitis

被引:20
作者
Barahona-Garrido, J. [1 ]
Camacho-Escobedo, J. [1 ]
Garcia-Martinez, C. I. [1 ]
Tocay, H. [1 ]
Cabiedes, J. [2 ]
Yamamoto-Furusho, J. K. [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Inflammatory Bowel Dis Clin, Mexico City 14000, DF, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City 14000, DF, Mexico
关键词
ulcerative colitis; antinuclear antibodies; inflammatory bowel disease; steroid dependence; extraintestinal manifestations; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; INFLAMMATORY-BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; AUTOANTIBODIES; THERAPY; SERUM;
D O I
10.1002/ibd.20852
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The autoimmune phenomena and the autoantibody profile have acquired great importance in ulcerative colitis (UC). Few studies have explored antinuclear antibodies (ANAs) prevalence, but not its association with steroid dependence. We hypothesized that ANAs could be a factor associated to steroid dependence. Methods: Ninety-seven consecutive patients with UC were in. patterns were determined by indirect chided. ANA titers and staining immunofluorescence. Gender, age, follow-up time, C-reactive protein (CRP), disease extent, Mayo Score Activity Index, extraintestinal manifestations, and steroid dependence were analyzed in univariate and multivariate models. Results: Ninety-seven Patients were included and 49 (50.5%) were females mean age was 41.7 +/- 22.2),cars. Positivity for ANAs was encountered in 52 (53.5%) patients, and none for anti-dsDNA. The prevalence of ANAs was higher in steroid-dependent than in nonsteroid-dependent patients (77.8% versus 48.1%, P = 0.020: odds ratio [OR] = 3.9, 95% confidence interval [CI] 1.1-12.5), and in those with uveitis (100% versus 51.1% P = 0.040) or pyodemia gangrenosum (100% versus 51.6%: P = 0.078). No association was observed with gender, age, CRP. disease extent, and Mayo Score Activity Index. The multiple regression analysis model showed all association between steroid dependence and ANAs (P = 0.033, OR = 3.9,95% Cl 1.4-14.9). Conclusions: ANAs are associated with steroid dependence in UC patients. Further studies are required to determine the role of ANAs as serological markers for prediction of steroid dependence in order to perform early therapeutic interventions with biological agents. (Inflamm Bowel Dis 2009:15:1039-1043)
引用
收藏
页码:1039 / 1043
页数:5
相关论文
共 28 条
[1]   EFFECT OF PROCTOCOLECTOMY ON SERUM ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PATIENTS WITH CHRONIC ULCERATIVE-COLITIS [J].
AITOLA, P ;
MIETTINEN, A ;
MATTILA, A ;
MATIKAINEN, M ;
SOPPI, E .
JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (07) :645-647
[2]  
ALVARADO A, 2006, DETERMINACION ANTICU
[3]   Inflammatory bowel disease: new insights into pathogenesis and treatment [J].
Ardizzone, S ;
Porro, GB .
JOURNAL OF INTERNAL MEDICINE, 2002, 252 (06) :475-496
[4]   Impact of race and ethnicity on inflammatory bowel disease [J].
Basu, D ;
Lopez, I ;
Kulkarni, A ;
Sellin, JH .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (10) :2254-2261
[5]   Laboratory testing in the rheumatic diseases: A practical review [J].
Colglazier, CL ;
Sutej, PG .
SOUTHERN MEDICAL JOURNAL, 2005, 98 (02) :185-191
[6]   A case of Sjogren's syndrome, sarcoidosis, previous ulcerative colitis and gastric autoantibodies [J].
Cox, NH ;
McCrea, JD .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 (06) :1138-1140
[7]   Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy [J].
De Rycke, L ;
Kruithof, E ;
Van Damme, N ;
Hoffman, IEA ;
Van den Bossche, N ;
Van den Bosch, F ;
Veys, EM ;
De Keyser, F .
ARTHRITIS AND RHEUMATISM, 2003, 48 (04) :1015-1023
[8]   Review article: biological activity markers in inflammatory bowel disease [J].
Desai, D. ;
Faubion, W. A. ;
Sandborn, W. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (03) :247-255
[9]   The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study [J].
Faubion, WA ;
Loftus, EV ;
Harmsen, WS ;
Zinsmeister, AR ;
Sandborn, WJ .
GASTROENTEROLOGY, 2001, 121 (02) :255-260
[10]   Antinuclear autoantibodies in patients with inflammatory bowel disease - High prevalence in first-degree relatives [J].
Folwaczny, C ;
Noehl, N ;
Endres, SP ;
Heldwein, W ;
Loeschke, K ;
Fricke, H .
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (08) :1593-1597